Financhill
Sell
41

ODFL Quote, Financials, Valuation and Earnings

Last price:
$181.40
Seasonality move :
9.17%
Day range:
$176.03 - $186.84
52-week range:
$165.49 - $233.26
Dividend yield:
0.57%
P/E ratio:
31.71x
P/S ratio:
6.67x
P/B ratio:
9.27x
Volume:
4.7M
Avg. volume:
1.5M
1-year change:
-9.77%
Market cap:
$38.7B
Revenue:
$5.9B
EPS (TTM):
$5.72
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $4.1B $4B $5.3B $6.3B $5.9B
Revenue Growth (YoY) 1.62% -2.29% 30.91% 19.1% -6.29%
 
Cost of Revenues $2.9B $2.8B $3.5B $4B $3.8B
Gross Profit $1.2B $1.2B $1.8B $2.3B $2.1B
Gross Profit Margin 28.48% 30.6% 33.77% 36.04% 35.33%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $206.1M $184.2M $223.8M $258.9M $281.1M
Other Inc / (Exp) -$1.1M -$4.6M -$2.2M -$2.6M -$5.2M
Operating Expenses $351.5M $321.7M $383.5M $415.5M $431.5M
Operating Income $818.7M $906.9M $1.4B $1.8B $1.6B
 
Net Interest Expenses -- $952K $941K -- --
EBT. Incl. Unusual Items $823.9M $901.4M $1.4B $1.8B $1.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $208.4M $228.7M $354M $464.2M $408.3M
Net Income to Company $615.5M $672.7M $1B $1.4B $1.2B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $615.5M $672.7M $1B $1.4B $1.2B
 
Basic EPS (Cont. Ops) $2.56 $2.86 $4.47 $6.13 $5.67
Diluted EPS (Cont. Ops) $2.55 $2.84 $4.45 $6.09 $5.63
Weighted Average Basic Share $240.8M $235.5M $231.3M $224.7M $218.8M
Weighted Average Diluted Share $241.2M $237M $232.8M $226.2M $220.2M
 
EBITDA $1.1B $1.2B $1.7B $2.1B $2B
EBIT $824.3M $904.1M $1.4B $1.8B $1.6B
 
Revenue (Reported) $4.1B $4B $5.3B $6.3B $5.9B
Operating Income (Reported) $818.7M $906.9M $1.4B $1.8B $1.6B
Operating Income (Adjusted) $824.3M $904.1M $1.4B $1.8B $1.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.1B $1.4B $1.6B $1.5B $1.5B
Revenue Growth (YoY) 0.93% 32.31% 14.55% -5.51% -2.97%
 
Cost of Revenues $705.3M $913.4M $995.1M $959.4M $955M
Gross Profit $352.9M $486.7M $608.5M $555.9M $515.2M
Gross Profit Margin 33.35% 34.76% 37.95% 36.69% 35.04%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $46.8M $61.7M $73.7M $68.5M $73.3M
Other Inc / (Exp) -$961K -$266K -$351K -$861K -$523K
Operating Expenses $82.6M $103.2M $112.5M $110.9M $113.3M
Operating Income $270.2M $383.4M $496.1M $445M $401.9M
 
Net Interest Expenses $948K $193K -- -- --
EBT. Incl. Unusual Items $268.3M $383M $496.1M $446.4M $403.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $66.5M $96.3M $118.7M $107.1M $94.5M
Net Income to Company $201.9M $286.6M $377.4M $339.3M $308.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $201.9M $286.6M $377.4M $339.3M $308.6M
 
Basic EPS (Cont. Ops) $0.86 $1.24 $1.69 $1.55 $1.44
Diluted EPS (Cont. Ops) $0.86 $1.24 $1.68 $1.54 $1.43
Weighted Average Basic Share $234.4M $230.8M $223.1M $218.4M $214.1M
Weighted Average Diluted Share $235.9M $232.3M $224.6M $219.7M $215.2M
 
EBITDA $334.4M $448.5M $565.4M $530.5M $489.8M
EBIT $269.4M $383.3M $497.1M $446.5M $403.1M
 
Revenue (Reported) $1.1B $1.4B $1.6B $1.5B $1.5B
Operating Income (Reported) $270.2M $383.4M $496.1M $445M $401.9M
Operating Income (Adjusted) $269.4M $383.3M $497.1M $446.5M $403.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4B $4.9B $6.2B $5.9B $5.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.8B $3.3B $4B $3.8B $3.8B
Gross Profit $1.2B $1.6B $2.2B $2.1B $2.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $195M $213.5M $253.2M $258.2M $300.2M
Other Inc / (Exp) -$4.6M -$2.1M -$2.2M -$5.2M -$3.4M
Operating Expenses $333.3M $365.3M $413.5M $421.4M $454.1M
Operating Income $840.8M $1.3B $1.8B $1.6B $1.6B
 
Net Interest Expenses -- $1.3M -- -- --
EBT. Incl. Unusual Items $837.6M $1.3B $1.8B $1.7B $1.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $210.8M $324.6M $449.1M $413.8M $402M
Net Income to Company $626.9M $945.4M $1.3B $1.2B $1.2B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $626.9M $945.4M $1.3B $1.2B $1.2B
 
Basic EPS (Cont. Ops) $2.65 $4.07 $5.88 $5.65 $5.75
Diluted EPS (Cont. Ops) $2.64 $4.05 $5.84 $5.62 $5.72
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $1.1B $1.5B $2.1B $2B $2B
EBIT $839.7M $1.3B $1.8B $1.7B $1.6B
 
Revenue (Reported) $4B $4.9B $6.2B $5.9B $5.9B
Operating Income (Reported) $840.8M $1.3B $1.8B $1.6B $1.6B
Operating Income (Adjusted) $839.7M $1.3B $1.8B $1.7B $1.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.9B $3.8B $4.8B $4.4B $4.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2B $2.5B $3B $2.8B $2.9B
Gross Profit $897M $1.3B $1.7B $1.5B $1.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $142.5M $171.8M $201.2M $200.6M $219.7M
Other Inc / (Exp) -$4.2M -$1.8M -$1.7M -$4.3M -$2.5M
Operating Expenses $244.4M $288M $318.1M $324M $346.5M
Operating Income $652.6M $1B $1.4B $1.2B $1.2B
 
Net Interest Expenses $1.5M $683K -- -- --
EBT. Incl. Unusual Items $648M $1B $1.4B $1.2B $1.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $165.2M $261.1M $356.1M $305.8M $299.5M
Net Income to Company $482.9M $755.6M $1.1B $916.7M $922.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $482.9M $755.6M $1.1B $916.7M $922.9M
 
Basic EPS (Cont. Ops) $2.05 $3.26 $4.67 $4.18 $4.27
Diluted EPS (Cont. Ops) $2.04 $3.24 $4.63 $4.16 $4.25
Weighted Average Basic Share $707.7M $695.5M $678.1M $657.3M $648.1M
Weighted Average Diluted Share $712.2M $700M $682.5M $661.4M $651.6M
 
EBITDA $846.1M $1.2B $1.6B $1.5B $1.5B
EBIT $650M $1B $1.4B $1.2B $1.2B
 
Revenue (Reported) $2.9B $3.8B $4.8B $4.4B $4.4B
Operating Income (Reported) $652.6M $1B $1.4B $1.2B $1.2B
Operating Income (Adjusted) $650M $1B $1.4B $1.2B $1.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $403.6M $401.4M $462.6M $186.3M $433.8M
Short Term Investments -- $330.3M $254.4M $49.4M --
Accounts Receivable, Net $397.6M $444.7M $567.5M $578.6M $578.9M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $55.1M $57.4M $67.7M $92.9M $94.2M
Total Current Assets $866.8M $1.2B $1.4B $933.7M $1.1B
 
Property Plant And Equipment $3B $2.9B $3.2B $3.7B $4.1B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $159.9M $212M $222.1M $217.8M $273.7M
Total Assets $4B $4.4B $4.8B $4.8B $5.5B
 
Accounts Payable $70.3M $68.5M $82.5M $106.3M $112.8M
Accrued Expenses $100.5M $104.6M $123.8M $115.2M $132.9M
Current Portion Of Long-Term Debt -- -- -- $20M $20M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $366.1M $373.1M $464.2M $529.8M $544.7M
 
Long-Term Debt $45M $99.9M $99.9M $80M $60M
Capital Leases -- -- -- -- --
Total Liabilities $914.9M $1B $1.1B $1.2B $1.3B
 
Common Stock $12M $11.7M $11.5M $11M $10.9M
Other Common Equity Adj -- -- -- -- --
Common Equity $3.1B $3.3B $3.7B $3.7B $4.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $3.1B $3.3B $3.7B $3.7B $4.3B
 
Total Liabilities and Equity $4B $4.4B $4.8B $4.8B $5.5B
Cash and Short Terms $403.6M $731.7M $717M $235.7M $433.8M
Total Debt $45M $99.9M $99.9M $100M $80M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $420.4M $339.8M $216.7M $206.6M $74.2M
Short Term Investments $205.3M $224.9M $158.8M -- --
Accounts Receivable, Net $453.3M $591.8M $630.4M $632.9M $545.7M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $49.9M $60.1M $81.8M $83.9M $84.2M
Total Current Assets $1.1B $1.3B $1.1B $954.2M $735.1M
 
Property Plant And Equipment $2.9B $3.1B $3.5B $4.1B $4.4B
Long-Term Investments -- -- -- -- --
Goodwill $19.5M -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $180.3M $224.2M $208.7M $259.2M $265M
Total Assets $4.3B $4.6B $4.8B $5.3B $5.4B
 
Accounts Payable $59.2M $135M $120.2M $115.7M $99.3M
Accrued Expenses $114.6M $155.1M $160.4M $138.6M $139.3M
Current Portion Of Long-Term Debt $45M -- $20M $20M $20M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $449.3M $534.3M $639.3M $552.4M $553.6M
 
Long-Term Debt $99.9M $99.9M $80M $60M $40M
Capital Leases -- -- -- -- --
Total Liabilities $1.1B $1.2B $1.3B $1.2B $1.3B
 
Common Stock $11.7M $11.5M $11.1M $10.9M $21.4M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $3.2B $3.4B $3.6B $4.1B $4.2B
 
Total Liabilities and Equity $4.3B $4.6B $4.8B $5.3B $5.4B
Cash and Short Terms $625.7M $564.7M $375.6M $206.6M $74.2M
Total Debt $144.9M $99.9M $100M $80M $60M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $615.5M $672.7M $1B $1.4B $1.2B
Depreciation & Amoritzation $253.7M $261.3M $259.9M $276.1M $324.4M
Stock-Based Compensation $16.7M $11.3M $15M $15.9M $11.1M
Change in Accounts Receivable $30.3M -$49M -$125.6M -$13M -$3.9M
Change in Inventories -- -- -- -- --
Cash From Operations $983.9M $933M $1.2B $1.7B $1.6B
 
Capital Expenditures $479.3M $225.1M $550.1M $775.1M $757.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$473.6M -$551.7M -$455.3M -$547.5M -$659.8M
 
Dividends Paid (Ex Special Dividend) -$54.6M -$71M -$92.4M -$134.5M -$175.1M
Special Dividend Paid
Long-Term Debt Issued -- $99.9M -- -- --
Long-Term Debt Repaid -- -$45M -- -- -$20M
Repurchase of Common Stock -$241M -$364.1M -$536.5M -$1.3B -$453.6M
Other Financing Activities -$1.4M -$3.3M -$67.4M -$8.7M -$13.1M
Cash From Financing -$297M -$383.5M -$696.2M -$1.4B -$661.8M
 
Beginning Cash (CF) $190.3M $403.6M $401.4M $462.6M $186.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $213.3M -$2.1M $61.1M -$276.3M $247.5M
Ending Cash (CF) $403.6M $401.4M $462.6M $186.3M $433.8M
 
Levered Free Cash Flow $504.6M $707.9M $662.5M $916.4M $811.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $201.9M $286.6M $377.4M $339.3M $308.6M
Depreciation & Amoritzation $65M $65.2M $68.4M $84.1M $86.7M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $170.2M $364.3M $514.2M $429.2M $446.5M
 
Capital Expenditures $46.3M $178.6M $181.7M $172M $242.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$250.9M -$235.7M -$114.6M -$167.4M -$201.4M
 
Dividends Paid (Ex Special Dividend) -$17.6M -$23M -$33.4M -$43.7M -$55.6M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -$256.3M -$345.4M -$65.9M -$187.7M
Other Financing Activities -- $6.2M -$165K -$859K -$1.9M
Cash From Financing -$17.6M -$273.1M -$379M -$110.4M -$245.2M
 
Beginning Cash (CF) $518.6M $484.2M $196.1M $55.1M $74.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$98.2M -$144.4M $20.6M $151.5M -$141K
Ending Cash (CF) $420.4M $339.8M $216.7M $206.6M $74.2M
 
Levered Free Cash Flow $123.9M $185.7M $332.5M $257.3M $203.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $626.9M $945.4M $1.3B $1.2B $1.2B
Depreciation & Amoritzation $260.7M $258.2M $270.8M $311.9M $340.4M
Stock-Based Compensation $11.4M -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $922.8M $1.1B $1.7B $1.5B $1.7B
 
Capital Expenditures $275.5M $443.3M $670.2M $921.7M $706.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$474.4M -$444.4M -$582.9M -$738.9M -$663.8M
 
Dividends Paid (Ex Special Dividend) -$67M -$86.9M -$124.4M -$164.5M -$211.8M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$342.4M -$593.7M -$1.1B -$568M -$870.3M
Other Financing Activities -$40.8M -$29.8M -$8.6M -$12.4M -$61.5M
Cash From Financing -$350.3M -$755.4M -$1.2B -$765M -$1.2B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $98.1M -$80.6M -$123M -$10.1M -$132.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $647.4M $675.9M $1B $572.1M $988.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $482.9M $755.6M $1.1B $916.7M $922.9M
Depreciation & Amoritzation $196.2M $193.1M $204M $239.8M $255.8M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $686.5M $872.6M $1.3B $1.1B $1.3B
 
Capital Expenditures $166.5M $384.7M $504.8M $651.4M $600.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$368.4M -$261.2M -$388.8M -$580.3M -$584.2M
 
Dividends Paid (Ex Special Dividend) -$53.5M -$69.4M -$101.4M -$131.5M -$168.2M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $99.9M -- -- -- --
Long-Term Debt Repaid -- -- -- -$20M -$20M
Repurchase of Common Stock -$306.8M -$536.5M -$1.1B -$368.1M -$784.8M
Other Financing Activities -$40.8M -$67.3M -$8.5M -$12.3M -$60.6M
Cash From Financing -$301.2M -$673.1M -$1.2B -$531.9M -$1B
 
Beginning Cash (CF) $1.3B $1.2B $920.8M $449.1M $1.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $16.8M -$61.7M -$245.8M $20.3M -$359.6M
Ending Cash (CF) $1.3B $1.2B $675M $469.4M $729.4M
 
Levered Free Cash Flow $520M $487.9M $825.5M $481.1M $657.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock